Eli Lilly

0
24h
2
7 days
▼3
8
30 days
32
All time

Activity (last 30 days)

Activity sparkline for the last 30 days, max 4 mentions in a single day.

Recent Topics AI-generated

  • Eli Lilly Dominates High-Growth Healthcare Market

    4 October 2026 · 2 Sources

  • Pharmaceutical ETF Comparison: VanEck PPH vs. Invesco PJP

    1 October 2026 · 2 Sources

  • Eli Lilly pharma chief criticizes German health policy

    30 September 2026 · 3 Sources

  • Bristol Myers Squibb Trades at Discount to Faster-Growing Eli Lilly

    29 September 2026 · 2 Sources

  • Lilly's Triple-Hormone Drug Delivers Record Weight Loss Results

    29 September 2026 · 2 Sources

  • Eli Lilly Poised for Anti-Obesity Market

    29 September 2026 · 3 Sources

  • Novo Nordisk Pursues Once-Daily Pill to Compete With Injections

    29 September 2026 · 2 Sources

  • Novo Nordisk Rebrands to Novo Amid Obesity Market Competition

    14 September 2026 · 5 Sources

  • Novartis Cholesterol Drug Fails Late-Stage Trial

    7 September 2026 · 2 Sources

  • Prescription Drug Costs Fall to Lowest Level in 60 Years

    17 August 2026 · 2 Sources

  • Nestlé Develops Ozempic Side-Effect Nutrition Products

    17 August 2026 · 3 Sources

  • Tribeca Film Festival Vital Stories Shorts Premiere

    16 August 2026 · 2 Sources

  • US Pharma Giant Launches Major Campaign in Danish Capital

    10 August 2026 · 2 Sources

  • Novo Nordisk Weight-Loss Pill Launches in Germany

    7 August 2026 · 2 Sources

  • Eli Lilly Gains on Weight-Loss Drug Demand

    5 August 2026 · 2 Sources

  • Eli Lilly Gains as Novo Nordisk Signals Slowdown

    5 August 2026 · 4 Sources

  • Novo Nordisk accelerates obesity drug market expansion

    3 August 2026 · 6 Sources

  • Eli Lilly stock reaches all-time high

    7 July 2026 · 2 Sources

  • Weight-Loss Drugs Propel Pharma Giant

    1 July 2026 · 2 Sources

  • Medicare Now Covers Obesity Drugs for Seniors

    27 June 2026 · 2 Sources

  • Pharma Giants Challenge Germany's Drug Price Controls

    23 June 2026 · 2 Sources

  • White House Rejects Trump Obesity Drug Access Speculation

    22 June 2026 · 7 Sources

  • Eli Lilly Pharmaceutical Factory Gets Dutch Council Approval

    17 June 2026 · 7 Sources

  • Medicare Weight-Loss Drug Coverage Could Strain Doctors

    15 June 2026 · 3 Sources

  • Banking Commentary on Tech and Sports Stocks

    13 June 2026 · 3 Sources

  • Drugmakers Race Obesity Treatment Market

    13 June 2026 · 1 Sources

Coverage by Quality Tier

44
A
18
B
1
C
0
D

Top Sources

  • The Motley Fool 6
  • CNBC 5
  • Børsen 4
  • FT Companies 3
  • NOS 2
  • Handelsblatt 2
  • Ars Technica 2
  • Cinco Días 2